• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2021年8月至9月法国重症监护病房新冠患者呼吸道样本中毛霉目检测的聚集性病例系列

A Clustered Case Series of Mucorales Detection in Respiratory Samples from COVID-19 Patients in Intensive Care, France, August to September 2021.

作者信息

Guemas Emilie, Cassaing Sophie, Malavaud Sandra, Fillaux Judith, Chauvin Pamela, Lelièvre Lucie, Ruiz Stéphanie, Riu Béatrice, Berry Antoine, Iriart Xavier

机构信息

Department of Parasitology and Mycology, Toulouse University Hospital, 31059 Toulouse, France.

Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse, CNRS UMR5051, INSERM UMR1291, UPS, 31024 Toulouse, France.

出版信息

J Fungi (Basel). 2022 Mar 3;8(3):258. doi: 10.3390/jof8030258.

DOI:10.3390/jof8030258
PMID:35330260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8948870/
Abstract

While COVID-19-associated pulmonary aspergillosis is now well described in developed countries, COVID-19-associated mucormycosis (CAM) has seemed to remain quite rare in Europe. A retrospective study was performed between March 2020 to September 2021 among COVID-19 adult patients in the intensive care unit (ICU) at Toulouse Hospital (Southern France). PCR screening on respiratory samples, which target or Mucorales DNA, were performed, and the number of fungal detections was evaluated monthly during the study period. During the 19 months of the study, 44 (20.3%) COVID-19 ICU patients had a positive PCR for , an overall rate in keeping with the incidence of ICU COVID-19 patients. Ten patients (7.1%) had a positive Mucorales PCR over the same period. Surprisingly, 9/10 had a positive / PCR in August-September 2021, during the fourth Delta SARS-CoV-2 variant wave. Epidemic investigations have identified a probable environmental cause linked to construction works in the vicinity of the ICU (high levels of airborne spores due to the mistaken interruption of preventive humidification and summer temperature). Even if CAM are apparently rare in Europe, a cluster can also develop in industrialised countries when environmental conditions (especially during construction work) are associated with a high number of COVID-19 patients in the ICU.

摘要

虽然在发达国家,与新冠病毒相关的肺曲霉病已有充分描述,但与新冠病毒相关的毛霉病(CAM)在欧洲似乎仍然相当罕见。2020年3月至2021年9月间,在法国南部图卢兹医院重症监护病房(ICU)的成年新冠患者中进行了一项回顾性研究。对呼吸道样本进行了针对毛霉目DNA 的PCR筛查,并在研究期间每月评估真菌检测数量。在19个月的研究期间,44名(20.3%)新冠ICU患者的PCR检测呈阳性,总体发生率与ICU新冠患者的发病率相符。同期有10名患者(7.1%)的毛霉目PCR检测呈阳性。令人惊讶的是,在2021年8月至9月,即第四波新冠病毒德尔塔变种流行期间,10名患者中有9名的曲霉/毛霉PCR检测呈阳性。流行病学调查确定了一个可能的环境原因,与ICU附近的建筑工程有关(由于预防性加湿的错误中断和夏季高温导致空气中孢子水平升高)。即使CAM在欧洲显然罕见,但在工业化国家,当环境条件(特别是在建筑工程期间)与ICU中大量新冠患者相关联时,也可能出现聚集性病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/8948870/676c42055d27/jof-08-00258-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/8948870/e1b16f68e4cf/jof-08-00258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/8948870/319c16686595/jof-08-00258-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/8948870/676c42055d27/jof-08-00258-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/8948870/e1b16f68e4cf/jof-08-00258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/8948870/319c16686595/jof-08-00258-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/8948870/676c42055d27/jof-08-00258-g003.jpg

相似文献

1
A Clustered Case Series of Mucorales Detection in Respiratory Samples from COVID-19 Patients in Intensive Care, France, August to September 2021.2021年8月至9月法国重症监护病房新冠患者呼吸道样本中毛霉目检测的聚集性病例系列
J Fungi (Basel). 2022 Mar 3;8(3):258. doi: 10.3390/jof8030258.
2
Quantitative PCR (qPCR) Detection of Mucorales DNA in Bronchoalveolar Lavage Fluid To Diagnose Pulmonary Mucormycosis.实时荧光定量 PCR 检测支气管肺泡灌洗液中毛霉目 DNA 对肺毛霉病的诊断价值。
J Clin Microbiol. 2018 Jul 26;56(8). doi: 10.1128/JCM.00289-18. Print 2018 Aug.
3
COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.新型冠状病毒肺炎相关混合霉菌感染:1例曲霉病和毛霉病病例报告及文献综述
J Mycol Med. 2022 Mar;32(1):101231. doi: 10.1016/j.mycmed.2021.101231. Epub 2021 Nov 26.
4
Absence of COVID-19 associated mucormycosis in a tertiary intensive care unit in the Netherlands.荷兰一家三级重症监护病房中 COVID-19 相关毛霉菌病的缺失。
Sci Rep. 2023 Dec 13;13(1):22134. doi: 10.1038/s41598-023-47231-4.
5
Case series of invasive lung infections by species and zygomycosis among post COVID-19 and post-transplant individuals.COVID-19康复者及移植后个体侵袭性肺部感染按菌种及接合菌病分类的病例系列
J Family Med Prim Care. 2022 Nov;11(11):7469-7475. doi: 10.4103/jfmpc.jfmpc_1066_22. Epub 2022 Dec 16.
6
COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.COVID-19 相关肺曲霉病:一项前瞻性单中心双病例系列研究。
Mycoses. 2021 Apr;64(4):457-464. doi: 10.1111/myc.13254. Epub 2021 Feb 16.
7
PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis.基于聚合酶链反应(PCR)的方法针对黏菌类特异性基因家族用于毛霉病的诊断。
J Clin Microbiol. 2018 Sep 25;56(10). doi: 10.1128/JCM.00746-18. Print 2018 Oct.
8
Evaluation of environmental Mucorales contamination in and around the residence of COVID-19-associated mucormycosis patients.评价 COVID-19 相关毛霉病患者住所及其周围环境中环境毛霉的污染情况。
Front Cell Infect Microbiol. 2022 Sep 2;12:953750. doi: 10.3389/fcimb.2022.953750. eCollection 2022.
9
Airborne fungal spores and invasive aspergillosis in hematologic units in a tertiary hospital during construction: a prospective cohort study.在一家三级医院的血液科在施工期间空气中的真菌孢子和侵袭性曲霉病:一项前瞻性队列研究。
Antimicrob Resist Infect Control. 2019 May 29;8:88. doi: 10.1186/s13756-019-0543-1. eCollection 2019.
10
Is Serum Ferritin an Early Marker for COVID-19-Associated Mucormycosis?血清铁蛋白是新型冠状病毒肺炎相关毛霉病的早期标志物吗?
Cureus. 2023 Mar 27;15(3):e36734. doi: 10.7759/cureus.36734. eCollection 2023 Mar.

引用本文的文献

1
The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European Perspective.真菌重点病原体清单对医学真菌学的影响:北欧视角
Open Forum Infect Dis. 2024 Jul 1;11(7):ofae372. doi: 10.1093/ofid/ofae372. eCollection 2024 Jul.
2
COVID-19, mucormycosis, and the cow: Damned lies!新型冠状病毒肺炎、毛霉菌病与牛:可恶的谎言!
Indian J Med Microbiol. 2023 Jul-Aug;44:100382. doi: 10.1016/j.ijmmb.2023.100382. Epub 2023 May 24.
3
Mucormycosis in a Patient with Severe COVID-19 Disease-The First Case Report in Romania and a Literature Review.

本文引用的文献

1
Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication.法国2019年冠状病毒病相关毛霉菌病:一种罕见但致命的并发症
Open Forum Infect Dis. 2021 Nov 6;9(2):ofab566. doi: 10.1093/ofid/ofab566. eCollection 2022 Feb.
2
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.COVID-19 机械通气患者真菌感染:法国多中心 MYCOVID 研究。
Lancet Respir Med. 2022 Feb;10(2):180-190. doi: 10.1016/S2213-2600(21)00442-2. Epub 2021 Nov 26.
3
COVID19 associated mucormycosis: Is GRP78 a possible link?
严重 COVID-19 疾病患者中的毛霉菌病:罗马尼亚首例病例报告及文献复习。
Medicina (Kaunas). 2023 Mar 11;59(3):555. doi: 10.3390/medicina59030555.
4
DectiSomes: C-type lectin receptor-targeted liposomes as pan-antifungal drugs.DectiSomes:靶向 C 型凝集素受体的脂质体作为泛抗真菌药物。
Adv Drug Deliv Rev. 2023 May;196:114776. doi: 10.1016/j.addr.2023.114776. Epub 2023 Mar 17.
5
Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review.新型冠状病毒肺炎相关毛霉菌病(CAM)的临床表型:一项综述
Diagnostics (Basel). 2022 Dec 8;12(12):3092. doi: 10.3390/diagnostics12123092.
COVID19 相关毛霉病:GRP78 是否是一个可能的联系?
J Infect Public Health. 2021 Oct;14(10):1351-1357. doi: 10.1016/j.jiph.2021.09.004. Epub 2021 Sep 10.
4
ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.ECMM/ISHAM 关于中低收入国家 COVID-19 相关毛霉菌病临床管理的建议。
Mycoses. 2021 Sep;64(9):1028-1037. doi: 10.1111/myc.13335. Epub 2021 Jul 26.
5
Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021.荷兰 2020 年 12 月至 2021 年 5 月期间 4 例 COVID-19 患者继发毛霉菌病的病例系列。
Euro Surveill. 2021 Jun;26(23). doi: 10.2807/1560-7917.ES.2021.26.23.2100510.
6
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.印度冠状病毒疾病相关毛霉菌病的多中心流行病学研究。
Emerg Infect Dis. 2021 Sep;27(9):2349-2359. doi: 10.3201/eid2709.210934. Epub 2021 Jun 4.
7
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.托珠单抗治疗 COVID-19 住院患者的疗效(RECOVERY):一项随机、对照、开放标签、平台试验。
Lancet. 2021 May 1;397(10285):1637-1645. doi: 10.1016/S0140-6736(21)00676-0.
8
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.2020年3月至8月与新型冠状病毒肺炎相关的肺曲霉病
Emerg Infect Dis. 2021;27(4):1077-1086. doi: 10.3201/eid2704.204895. Epub 2021 Feb 4.
9
Mixed mold infection with and in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient.一名严重急性呼吸综合征冠状病毒2(SARS-CoV-2)患者合并 和 的混合霉菌感染。 (你提供的原文中“ 和 ”部分内容缺失,请补充完整以便更准确翻译)
Infect Dis Now. 2021 Oct;51(7):633-635. doi: 10.1016/j.idnow.2021.01.010. Epub 2021 Jan 27.
10
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.定义和管理新型冠状病毒肺炎相关肺曲霉病:2020年欧洲临床微生物与感染性疾病学会/国际人类与动物真菌学会研究和临床指南共识标准
Lancet Infect Dis. 2021 Jun;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1. Epub 2020 Dec 14.